In this study, we investigated whether DNA methylation, changes in mRNA and protein expression, and potential epigenetic silencing of CDH3 occur in RCC, and correlated the presence of such changes with the histopathological and clinical characteristics of patients. This evidence concerns the gene CDH3 and renal cell carcinoma.